Literature DB >> 26905569

Concomitant Migraine and Temporomandibular Disorders are Associated With Higher Heat Pain Hyperalgesia and Cephalic Cutaneous Allodynia.

Thais C Chaves1, Fabíola Dach, Lidiane L Florencio, Gabriela F Carvalho, Maria C Gonçalves, Marcelo E Bigal, José G Speciali, Débora Bevilaqua-Grossi.   

Abstract

OBJECTIVES: The aim of this study was to assess differences in the levels of hyperalgesia and cutaneous allodynia (CA) among women with migraine, temporomandibular disorders (TMD), or both.
MATERIALS AND METHODS: Eighty women participated in the study. Mean ages for the control group, TMD group, migraine group, and migraine+TMD group were 26.15 (95% confidence interval [CI], 28.73 to 23.57), 31.65 (95% CI, 37.82 to 25.48), 35.05 (95% CI, 40.37 to 29.73), and 34.20 (95% CI, 37.99 to 30.41) years, respectively. The 12-item Allodynia Symptom Checklist was administered to assess CA. All participants underwent the Quantitative Sensory Test to determine the cold-pain and heat-pain thresholds. Mechanical pain thresholds were assessed using Semmes-Weinstein monofilaments. One-way analysis of variance and χ tests were used for statistical analysis. Alpha was set at 0.05 level for statistical significance.
RESULTS: For all sites evaluated, the mean cold-pain threshold values were significantly lower in the TMD, migraine, and TMD+migraine groups compared with the control group. However, the mean heat-pain threshold values in the extracephalic region were significantly smaller only for the TMD+migraine group compared with the control group (41.94°C; 95% CI, 40.54 to 43.34 vs. 44.79°C; 95% CI, 43.45 to 46.12; P=0.03). Mechanical hyperalgesia in orofacial and neck sites was significantly lower in the TMD and TMD+migraine groups compared with the control group. Mean total 12-item Allodynia Symptom Checklist score in the TMD+migraine group was significantly higher than in the migraine group (9.53; 95% CI, 7.45 to 11.60 vs. 6.95; 95% CI, 5.35 to 8.55; P=0.02).
CONCLUSIONS: More pronounced levels of hyperalgesia and CA were found in patients with both TMD and migraine. Thus, it is suggested that the concomitant presence of TMD and migraine may be related to intensification of central sensitization.

Entities:  

Mesh:

Year:  2016        PMID: 26905569     DOI: 10.1097/AJP.0000000000000369

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  8 in total

1.  Migraine disability, pain catastrophizing, and headache severity are associated with evoked pain and targeted by mind-body therapy.

Authors:  Samuel R Krimmel; Michael L Keaser; Darrah Speis; Jennifer A Haythornthwaite; David A Seminowicz
Journal:  Pain       Date:  2022-01-17       Impact factor: 7.926

2.  Phenotypic Features of Central Sensitization.

Authors:  David A Williams
Journal:  J Appl Biobehav Res       Date:  2018-06-27

3.  5-HT3/7 and GABAB receptors mediate inhibition of trigeminal nociception by dietary supplementation of grape seed extract.

Authors:  Lauren E Cornelison; Sara E Woodman; Paul L Durham
Journal:  Nutr Neurosci       Date:  2021-02-05       Impact factor: 4.062

4.  Mechanical Punctate Pain Thresholds in Patients With Migraine Across Different Migraine Phases: A Narrative Review.

Authors:  Li-Ling Hope Pan; Rolf-Detlef Treede; Shuu-Jiun Wang
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

5.  Inhibition of Nociception in a Preclinical Episodic Migraine Model by Dietary Supplementation of Grape Seed Extract Involves Activation of Endocannabinoid Receptors.

Authors:  Sara E Woodman; Sophia R Antonopoulos; Paul L Durham
Journal:  Front Pain Res (Lausanne)       Date:  2022-01-27

6.  Telerehabilitation proposal of mind-body technique for physical and psychological outcomes in patients with fibromyalgia.

Authors:  Teresa Paolucci; Alessandro de Sire; Martina Ferrillo; Dania di Fabio; Aurora Molluso; Antonia Patruno; Mirko Pesce; Carlo Lai; Chiara Ciacchella; Aristide Saggino; Francesco Agostini; Marco Tommasi
Journal:  Front Physiol       Date:  2022-08-26       Impact factor: 4.755

7.  Cross-cultural adaptation, reliability and validity of the Italian version of the craniofacial pain and disability inventory in patients with chronic temporomandibular joint disorders.

Authors:  Marco Monticone; Barbara Rocca; Paola Abelli; Simona Tecco; Tommaso Geri; Enrico Felice Gherlone; Deborah Luzzi; Marco Testa
Journal:  BMC Oral Health       Date:  2019-11-12       Impact factor: 2.757

Review 8.  Is Irritable Bowel Syndrome Considered in Clinical Trials on Physical Therapy Applied to Patients with Temporo-Mandibular Disorders? A Scoping Review.

Authors:  Daiana P Rodrigues-de-Souza; Javier Paz-Vega; César Fernández-de-Las-Peñas; Joshua A Cleland; Francisco Alburquerque-Sendín
Journal:  Int J Environ Res Public Health       Date:  2020-11-17       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.